<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829470/" ref="ordinalpos=203&amp;ncbi_uid=5492641&amp;link_uid=PMC3829470" image-link="/pmc/articles/PMC3829470/figure/F1/" class="imagepopup">Fig. (1).  From: <span class="highlight" style="background-color:">Signaling</span> Through Rho GTPase <span class="highlight" style="background-color:">Pathway</span> as Viable Drug Target. </a></div><br /><div class="p4l_captionBody">Schematic illustration of Rho GTPase signaling pathway. A. Receptor dependent and independent signaling through Rho GTPase pathway leading to actin reorganization. Numbered arrows indicate where the inhibitor targets are in the Rho GTPase signaling cascade: 1, Y27632, fasudil, and H-1152; 2, LM11A31; 3, statins; 4, NSC23766; 5, CCG-1423. B. Regulation of Rho GTPase activation and inactivation through Rho-GEFs, Rho-GAPs, and RhoGDIs.</div></div>